NORAD

ncRNA information

ncRNA name

NORAD

Specific or universal ncRNAs

Universal ncRNAs

Class

Long noncoding RNA

Biomarker

None

Biomarker application

Upstream regulatory factors

Not available

Downstream target

miR-224-3p/MTDH

Cancer information

Cancer name

Esophageal Squamous Cell Carcinoma

Cancer site

qRT-PCR,Western blot,Luciferase assay

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

NORAD upregulates MTDH to promote CDDP resistance and progression in ESCC by sponging miR-224-3p

Tissue resource

esophageal squamous cell carcinoma and matched paracarcinoma tissue specimens

Experiment

None


Institute

Fourth Hospital of Hebei Medical University

Country

China

Continent

Asia